Infectious Diseases (except HIV/AIDS)
-
Controlling the Worldwide Chaotic Spreading of COVID-19 through Vaccinations
This article has 2 authors:Reviewed by ScreenIT
-
Three-month follow-up of durability of response to the third dose of the SARS-CoV-2 BNT162b2 vaccine in adults aged 60 years and older: a prospective cohort study
This article has 13 authors:Reviewed by ScreenIT
-
Omicron variant Spike-specific antibody binding and Fc activity are preserved in recipients of mRNA or inactivated COVID-19 vaccines
This article has 14 authors:Reviewed by ScreenIT
-
Effectiveness of Casirivimab-Imdevimab and Sotrovimab During a SARS-CoV-2 Delta Variant Surge
This article has 41 authors:Reviewed by ScreenIT
-
Analysis of anti-Omicron neutralizing antibody titers in different vaccinated and unvaccinated convalescent plasma sources
This article has 5 authors:Reviewed by ScreenIT
-
Neutralizing antibodies to SARS‐CoV‐2 Omicron variant after third mRNA vaccination in health care workers and elderly subjects
This article has 8 authors:Reviewed by ScreenIT
-
CMV seropositivity is a potential novel risk factor for severe COVID-19 in non-geriatric patients
This article has 18 authors:Reviewed by ScreenIT
-
Echinacea as a Potential Force against Coronavirus Infections? A Mini-Review of Randomized Controlled Trials in Adults and Children
This article has 6 authors:Reviewed by ScreenIT
-
Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo-controlled, phase 2 trial
This article has 42 authors:Reviewed by ScreenIT
-
Influenza A H1N1–mediated pre-existing immunity to SARS-CoV-2 predicts COVID-19 outbreak dynamics
This article has 18 authors:Reviewed by ScreenIT